News - Page 5 of 8 - Cyclotek

Cyclotek Initiates the Direct-Action Donation (DAD) of $45,000 for the Think Pink Foundation.

Posted on: 16 February 2021Latest News

In March 2020 Cyclotek announced the introduction of the Direct-Action Donations fund (DAD) t
read More
The Australian Translational Medicinal Chemistry Facility (ATMCF), Therapeutic Innovation Australia (TIA) Pipeline Accelerator 2019-20 project award:

Posted on: 26 October 2020Uncategorized

Development of radioligands as a diagnostic tool in cancer treatment Partner – Cyclotek
read More
Cyclotek acquires the business of Pettech Solutions Pty Ltd

Posted on: 17 January 2019Company

Media Release : 7 January 2
read More
Advancing Molecular Imaging in NSW

Posted on: 16 March 2018Company

CYCLOTEK NOW IN SYDNEY
read More
Neuroinflammation as a Mechanism, Biomarker, and Therapeutic Target in Degenerative Brain Disorders

Posted on: 15 October 2017Research

Immune-responsive cells of the brain – namely microglia and astrocytes – activate in resp
read More
Advancing Molecular Imaging in NSW

Posted on: 19 September 2017Company

Media Release 19 September 2017 Cyclotek, Cyclopharm, PETTECH Solutions and Macquarie Univers
read More

© 2024 Cyclotek. All rights reserved

[contact-form-7 id=”714″ title=”Update Form”]